House Bill No. 606, introduced by Representative Turner, aims to exempt prescription drugs and insulin from local sales and use taxes in Louisiana. The bill enacts new provisions in R.S. 47:305.2, specifically adding exemptions for drugs prescribed by licensed medical professionals and for both prescription and nonprescription insulin. Additionally, it repeals certain existing provisions in R.S. 47:305.2 that previously governed these exemptions, thereby streamlining the law to ensure that these essential medical items are free from both state and local sales taxes.

The proposed law will take effect for taxable periods beginning on or after August 1, 2025, thereby providing a clear timeline for implementation. This legislation is designed to alleviate the financial burden on individuals purchasing necessary medications, ensuring that both prescription drugs and insulin are accessible without the added cost of local sales taxes.

Statutes affected:
HB606 Original: 47:2(A)(1)
HB606 Engrossed: 47:2(A)(1)